Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
Plastic surgeon Paul S. Kim, MD, discusses his role in the Renewing Lives campaign and how minimally invasive skin-tightening treatments like Renuvion are helping patients address post-weight loss skin laxity.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.